Andreessen Horowitz December 19, 2020
Lauren Richardson and a16z

There is no question that the biggest, most significant scientific story of 2020 is the work to understand, treat, and vaccinate against COVID-19. But the story doesn’t end there. Across bio, but particularly at the powerful interface of biology and technology, there have been a number of significant advances this year. Our podcast show “Journal Club” — which was launched in April on the a16z Podcast and is now part of Bio Eats World — curates groundbreaking new scientific articles, digs into the details and the key implications, and covers how to translate these new insights from paper to practice.

As the host of Journal Club, I’ve spent the last 9 months immersed in the scientific literature (well, 5 years...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine
Top 20 pharma companies by 2023 revenue
Regeneron launches $500m venture capital arm
STAT+: Pharmalittle: We’re reading about a J&J cough syrup, a Pfizer and Moderna patent suit, and more
Pharma Pulse 4/15/24: Human Oversight with AI in Clinical Research, The Health and Healthcare of Gen Xers
STAT+: Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle

Share This Article